Response to: 'Umbilical-cord messenchymal stem cells for the treatment of automimmune diseases: beware of cell to cell contact' by Alunno et al

Affiliations

¹ ClinReserach SB, Petaling Jaya, Selangor, Malaysia.
² Second Affiliated Hospital of Kunming Medical University, SLE Research Centre, Kunming, Yunnan, China.

Comment

Teck Onn Lim et al. Ann Rheum Dis. 2018 Mar.

. 2018 Mar;77(3):e15.

doi: 10.1136/annrheumdis-2017-211808. Epub 2017 Jun 29.

¹ ClinReserach SB, Petaling Jaya, Selangor, Malaysia.
² Second Affiliated Hospital of Kunming Medical University, SLE Research Centre, Kunming, Yunnan, China.

No abstract available

Keywords: autoimmune diseases; disease activity; systemic lupus erythematosus.

Conflict of interest statement

Competing interests: None declared.

A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.
Deng D, Zhang P, Guo Y, Lim TO. Deng D, et al. Ann Rheum Dis. 2017 Aug;76(8):1436-1439. doi: 10.1136/annrheumdis-2017-211073. Epub 2017 May 6. Ann Rheum Dis. 2017. PMID: 28478399 Clinical Trial.
Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact.
Alunno A, Bistoni O, Montanucci P, Basta G, Calafiore R, Gerli R. Alunno A, et al. Ann Rheum Dis. 2018 Mar;77(3):e14. doi: 10.1136/annrheumdis-2017-211790. Epub 2017 Jun 13. Ann Rheum Dis. 2018. PMID: 28611081 No abstract available.